D. Rutledge

发表

Dose response of inhaled gallopamil (D600), a calcium channel blocker, in attenuating airway reactivity to methacholine and exercise.

L. Hendeles, R. Ahrens, E. Harman, 1988, The Journal of allergy and clinical immunology.

Clinical outcomes in real‐world patients with bifurcation lesions receiving Xience V everolimus‐eluting stents: Four‐year results from the Xience V USA study

M. Krucoff, Jin Wang, J. Hermiller, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Clinical outcomes in real‐world patients with small vessel disease treated with XIENCE V® everolimus‐eluting stents: One year results from the XIENCE V® USA condition of approval post‐market study

Samin K. Sharma, M. Krucoff, Jin Wang, 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Stent Thrombosis and Dual Antiplatelet Therapy Interruption With Everolimus-Eluting Stents: Insights From the Xience V Coronary Stent System Trials

P. Serruys, G. Stone, M. Krucoff, 2015, Circulation. Cardiovascular interventions.

SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomes.

S. Windecker, M. Morice, G. Mikhail, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Analysis of two variants of the angiotensinogen gene in essential hypertensive African-Americans.

P. Kubilis, E. Ross, D. Rutledge, 1994, American journal of hypertension.

Frequencies of the angiotensinogen gene and angiotensin I converting enzyme (ACE) gene polymorphisms in African Americans.

E. Ross, D. Rutledge, C. Browe, 1994, Biochemistry and molecular biology international.

Race and hypertension. What is clinically relevant?

D. Rutledge, 1994, Drugs.

Evaluation of Intravenous Amrinone: The First of a New Class of Positive Inotropic Agents with Vasodilator Properties

M. Bottorff, J. Pieper, D. Rutledge, 1985, Pharmacotherapy.

The Effect of pH on Gallopamil Protein Binding

D. Rutledge, Mark C Szlaczky, 1988, Pharmaceutical Research.

Gallopamil binding to human serum proteins

J. Pieper, D. Rutledge, 2004, European Journal of Clinical Pharmacology.

Polymorphisms within the atrial natriuretic peptide gene in essential hypertension

E. Ross, D. Rutledge, Yan-sun Sun, 1995, Journal of hypertension.

Preventing and Treating Hypertension: Can We Do Better?

D. Rutledge, 1993, The Annals of pharmacotherapy.

Safety and Effectiveness of Everolimus-Eluting Stents in Chronic Total Coronary Occlusion Revascularization: Results From the EXPERT CTO Multicenter Trial (Evaluation of the XIENCE Coronary Stent, Performance, and Technique in Chronic Total Occlusions).

J. Moses, A. Kini, D. Kandzari, 2015, JACC. Cardiovascular interventions.

Are There Beta-Adrenergic Receptor Response Differences between Racial Groups?

D. Rutledge, 1991, DICP : the annals of pharmacotherapy.

CORONARY Safety and Effectiveness of Everolimus-Eluting Stents in Chronic Total Coronary Occlusion Revascularization Results From the EXPERT CTO Multicenter Trial ( Evaluation of the XIENCE Coronary Stent , Performance , and Technique in Chronic Total Occlusions )

J. Moses, A. Kini, D. Kandzari, 2017 .

Effect of Age on Lymphocyte Beta2-Adrenergic Responsiveness

J. Steinberg, J. Steinberg, D. Rutledge, 1991, DICP : the annals of pharmacotherapy.

Racial Differences in Drug Response: Isoproterenol Effects Before and After Propranolol

S. Lavine, L. Cardozo, J. Steinberg, 1991, Pharmaceutical Research.

Rapid high-performance liquid chromatographic method for the measurement of the enantiomers of metoprolol in serum using a chiral stationary phase.

D. Rutledge, C. Garrick, 1989, Journal of chromatography.

Race and Hypertension

D. Rutledge, 1994, Drugs.

Sustained low clinical event rates in real-world patients receiving everolimus-eluting coronary stent system from a large, prospective, condition of approval study: 2-year clinical outcomes from the XIENCE V USA Study.

Samin K. Sharma, M. Krucoff, Jin Wang, 2012, Journal of interventional cardiology.

Racial differences in drug response: Isoproterenol effects on heart rate following intravenous metoprolol

L. Cardozo, J. Steinberg, D R Rutledge, 1989, Clinical pharmacology and therapeutics.

TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium.

K. Anstrom, L. Newby, A. Jacobs, 2013, American heart journal.

Contemporary incidence and predictors of stent thrombosis and other major adverse cardiac events in the year after XIENCE V implantation: results from the 8,061-patient XIENCE V United States study.

M. Krucoff, S. Naidu, J. Hermiller, 2012, JACC. Cardiovascular interventions.

CLINICAL OUTCOMES IN REAL-WORLD PATIENTS RECEIVING THE XIENCE V® EVEROLIMUS-ELUTING STENT PRESENTING WITH CHRONIC KIDNEY DISEASE: ONE-YEAR RESULTS FROM THE XIENCE V USA STUDY

A. Jeremias, M. Krucoff, Jin Wang, 2011 .

Clinical outcomes in real‐world patients with acute myocardial infarction receiving XIENCE V® everolimus‐eluting stents

T. Henry, S. Naidu, Jin Wang, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Liquid chromatographic determination of celiprolol, diltiazem, desmethyldiltiazem and deacetyldiltiazem in plasma using a short alkyl chain silanol deactivated column.

A. Abadi, L. Lopez, D. Rutledge, 1994, Journal of pharmaceutical and biomedical analysis.

High-performance liquid chromatographic determination of diltiazem and two of its metabolites in plasma using a short alkyl chain silanol deactivated column.

A. Abadi, L. Lopez, D. Rutledge, 1993, Journal of chromatography.

Racial Differences in Drug Response: Isoproterenol Effects on Heart Rate in Healthy Males

L. Cardozo, J. Steinberg, D. Rutledge, 1989, Pharmaceutical Research.

Determination of metoprolol and its alpha-hydroxide metabolite in serum by reversed-phase high-performance liquid chromatography.

D. Rutledge, C. Garrick, 1989, Journal of chromatographic science.

A new era of prospective real-world safety evaluation primary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-market study).

Mitchell W Krucoff, Weiying Zhao, Lalitha Jonnavithula, 2011, JACC. Cardiovascular interventions.

Clinical outcomes in the percutaneous coronary intervention of in-stent restenosis with everolimus-eluting stents.

E. Mahmud, M. Krucoff, G. Dangas, 2014, The Journal of invasive cardiology.

Effects of chronic phenobarbital on verapamil disposition in humans.

D. Mirvis, J. Pieper, D. Rutledge, 1988, The Journal of pharmacology and experimental therapeutics.

Interspecies differences in the effect of pH on gallopamil protein binding to albumin and α1-acid glycoprotein

M. V. Nelson, D. Rutledge, M. Chong, 2004, European Journal of Clinical Pharmacology.